Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Change in Receivables (2023)

Historic Change in Receivables for Tango Therapeutics (TNGX) over the last 1 years, with Q1 2023 value amounting to -$2.0 million.

  • Tango Therapeutics' Change in Receivables changed N/A to -$2.0 million in Q1 2023 from the same period last year, while for Dec 2023 it was -$2.0 million, marking a year-over-year change of. This contributed to the annual value of -$2.0 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Tango Therapeutics reported Change in Receivables of -$2.0 million as of Q1 2023.
  • Tango Therapeutics' Change in Receivables' 5-year high stood at -$2.0 million during Q1 2023, with a 5-year trough of -$2.0 million in Q1 2023.